ISSN: 2381-8727

International Journal of Inflammation, Cancer and Integrative Therapy
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Expert Review   
  • Int J Inflam Cancer Integr Ther,

Gemcitabine and Triapine Co-Delivery Using Calcium Carbonate Nanoparticles for the Treatment of Chemo-resistant Pancreatic Cancer

Tiaqing Li*
NICM Health Research Institute, Western Sydney University, Westmead, Australia
*Corresponding Author : Tiaqing Li, NICM Health Research Institute, Western Sydney University, Westmead, Australia, Email: tiaqing.li@gmail.com

Received Date: Mar 28, 2023 / Published Date: Apr 28, 2023

Abstract

Chemotherapy is the primary component of the systemic treatment strategy for pancreatic cancer, which is a fatal disease. However, patients with pancreatic cancer still have a very poor overall prognosis and a low survival rate. Gemcitabine (GEM) is a chemotherapeutic agent that is frequently used to treat pancreatic cancer. However, the primary obstacle remains GEM chemoresistance. To address the issue of Triapine's poor solubility and suppress the GEM resistance of pancreatic cancer cells (PANC-1/GEM), we prepared calcium carbonate nanoparticles (CaCO3 NPs) loaded with a nucleotide reductase inhibitor (Triapine). Using both 2D PANC-1/GEM cells and 3D tumor spheroids, CaCO3-GEM-Triapine NPs nano-formulations inhibited cancer cell proliferation, migration, and resistance to GEM, enhancing the therapeutic effect of GEM-based chemotherapy. According to the findings of the study, CaCO3 NPs containing GEM and Triapine may be an efficient treatment option for overcoming drug resistance in pancreatic cancer.

Citation: Li T (2023) Gemcitabine and Triapine Co-Delivery Using Calcium Carbonate Nanoparticles for the Treatment of Chemo-resistant Pancreatic Cancer. Int J Inflam Cancer Integr Ther, 10: 212.

Copyright: © 2023 Li T. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Top